IN8bio Inc (INAB) Stock Price, Quote, News & History

INABNASDAQ
$0.9888
0.02872.99%
At close: Aug 5, 5:00 PM EST
$0.9887
-0.0001-0.01%
After Hours: 6:55 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-14.54M
Investing Cash Flow (TTM)
-9.00K
Financing Cash Flow (TTM)
24.55M
Free Cash Flow (TTM)
-14.55M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
10.00M

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$10.13M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.42
Earnings Yield % (TTM)
-264.56%
Earnings Yield % (FWD)
-232.27%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.31

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$575.00K
Total Cash
$21.94M
Debt to Equity
0.10
Issuance of Debt (TTM)
-$575.00K
Repayment of Debt (TTM)
-$575.00K

Key Statistics

Open
$1.00
Close
$0.99
Volume / Avg.
39.88K / 57.63K
Day Range
$0.94 - $1.00
52 Wk Range
0.94 - 2.73
Market Cap
$9.48M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
26
Short Interest
0.24%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy IN8bio (INAB) stock?

A

You can purchase shares of IN8bio (NASDAQ:INAB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are IN8bio (INAB) competitors?

A

There are no as such competitors for IN8bio.

Q

What is the forecast, or price target, for IN8bio (INAB) stock?

A

IN8bio has a consensus price target of $4.92.

Q

What is the current price for IN8bio (INAB)?

A

The stock price for IN8bio (NASDAQ: INAB) is $0.9887 last updated August 5, 2026 at 6:55 PM EDT.

Q

Does IN8bio (INAB) pay a dividend?

A

There are no upcoming dividends for IN8bio.

Q

When is IN8bio (NASDAQ:INAB) reporting earnings?

A

IN8bio does not have any upcoming earnings scheduled.

Q

Is IN8bio (INAB) going to split?

A

There is no upcoming split for IN8bio.

Q

What sector and industry does IN8bio (INAB) operate in?

A

IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.